Roche Czech Republic made a net profit of CZK 51.0 mil in 2015, down 46.3% when compared to the last year. Total sales reached CZK 5,445 mil, which is up 24.8% when compared to the previous year.
Historically, the company’s net profit reached an all time high of CZK 135 mil in 2013 and an all time low of CZK 16.8 mil in 2007.
In terms of sales, Roche Czech Republic reached an all time high of CZK 5,445 mil in 2015 and an all time low of CZK 2,879 mil in 2004.
Roche Czech Republic's net profit has grown -12.8% a year on average in the last five years while sales have increased by 1.42% a year since 2010.
The firm generated its shareholders an average return on invested capital of 4.84% in the last five years.
As far as Roche Czech Republic's peers are concerned, Bayer Czech Republic posted a net profit and sales of CZK 123 mil and CZK 4,277 mil in 2015 and Amgen Czech Republic generated a net profit of CZK 35.8 mil (with sales of CZK 604 mil).